Suppr超能文献

急性心肌梗死中祖细胞移植与再生增强研究(TOPCARE-AMI)

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).

作者信息

Assmus Birgit, Schächinger Volker, Teupe Claudius, Britten Martina, Lehmann Ralf, Döbert Natascha, Grünwald Frank, Aicher Alexandra, Urbich Carmen, Martin Hans, Hoelzer Dieter, Dimmeler Stefanie, Zeiher Andreas M

机构信息

Department of Molecular Cardiology, University of Frankfurt, Frankfurt, Germany.

出版信息

Circulation. 2002 Dec 10;106(24):3009-17. doi: 10.1161/01.cir.0000043246.74879.cd.

Abstract

BACKGROUND

Experimental studies suggest that transplantation of blood-derived or bone marrow-derived progenitor cells beneficially affects postinfarction remodeling. The safety and feasibility of autologous progenitor cell transplantation in patients with ischemic heart disease is unknown.

METHODS AND RESULTS

We randomly allocated 20 patients with reperfused acute myocardial infarction (AMI) to receive intracoronary infusion of either bone marrow-derived (n=9) or circulating blood-derived progenitor cells (n=11) into the infarct artery 4.3+/-1.5 days after AMI. Transplantation of progenitor cells was associated with a significant increase in global left ventricular ejection fraction from 51.6+/-9.6% to 60.1+/-8.6% (P=0.003), improved regional wall motion in the infarct zone (-1.5+/-0.2 to -0.5+/-0.7 SD/chord; P<0.001), and profoundly reduced end-systolic left ventricular volumes (56.1+/-20 mL to 42.2+/-15.1 mL; P=0.01) at 4-month follow-up. In contrast, in a nonrandomized matched reference group, left ventricular ejection fraction only slightly increased from 51+/-10% to 53.5+/-7.9%, and end-systolic volumes remained unchanged. Echocardiography revealed a profound enhancement of regional contractile function (wall motion score index 1.4+/-0.2 at baseline versus 1.19+/-0.2 at follow-up; P<0.001). At 4 months, coronary blood flow reserve was significantly (P<0.001) increased in the infarct artery. Quantitative F-18-fluorodeoxyglucose-positron emission tomography analysis revealed a significant (P<0.01) increase in myocardial viability in the infarct zone. There were no differences for any measured parameter between blood-derived or bone marrow-derived progenitor cells. No signs of an inflammatory response or malignant arrhythmias were observed.

CONCLUSIONS

In patients with AMI, intracoronary infusion of autologous progenitor cells appears to be feasible and safe and may beneficially affect postinfarction remodeling processes.

摘要

背景

实验研究表明,移植血液来源或骨髓来源的祖细胞对心肌梗死后的重塑有有益影响。自体祖细胞移植在缺血性心脏病患者中的安全性和可行性尚不清楚。

方法与结果

我们将20例再灌注急性心肌梗死(AMI)患者随机分为两组,在AMI后4.3±1.5天,一组(n = 9)经冠状动脉向梗死相关动脉内注入骨髓来源的祖细胞,另一组(n = 11)注入循环血液来源的祖细胞。祖细胞移植后,整体左心室射血分数从51.6±9.6%显著增加至60.1±8.6%(P = 0.003),梗死区域的局部室壁运动得到改善(从-1.5±0.2至-0.5±0.7标准差/弦;P < 0.001),并且在4个月随访时,左心室收缩末期容积显著降低(从56.1±20 mL降至42.2±15.1 mL;P = 0.01)。相比之下,在一个非随机匹配的参照组中,左心室射血分数仅从51±10%轻微增加至53.5±7.9%,收缩末期容积保持不变。超声心动图显示局部收缩功能显著增强(基线时室壁运动评分指数为1.4±0.2,随访时为1.19±0.2;P < 0.001)。在4个月时,梗死相关动脉的冠状动脉血流储备显著增加(P < 0.001)。定量F-18-氟脱氧葡萄糖-正电子发射断层扫描分析显示梗死区域的心肌存活能力显著增加(P < 0.01)。血液来源或骨髓来源的祖细胞之间,任何测量参数均无差异。未观察到炎症反应或恶性心律失常的迹象。

结论

在AMI患者中,经冠状动脉注入自体祖细胞似乎是可行且安全的,并且可能对心肌梗死后的重塑过程产生有益影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验